摘要
Precision medicine based on the accurate and comprehensive molecular characterization of tumors has become the most promising therapeutic strategy for cancer.In current clinical practice,patients with cancer normally receive the same treatment as other patients with the same type of cancer.
基金
supported by grants from National Natural Science Foundation of China (Grant No. 21974094, 21575103)
Tianjin Natural Science Foundation (Grant No. 18JCYBJC25200)
Young Elite Scientists Sponsorship Program by Tianjin (Grant No. TJSQNTJ-2017-10)
